We are delighted to announce that Cambridge Bioscience has partnered with InVitria, a leading developer and manufacturer of recombinant proteins and supplements.
InVitria provides fully recombinant, fully human protein supplements suitable for regulatory-friendly, serum-reduced, or serum-free culture of stem cells, isolated primary cells, and more. Their products are used by pioneers in biomanufacturing and the final formulation of vaccines, biologic medicines, cell therapies, gene therapies, and regenerative medicines. Their products are designed for sustainability, utilising their ExpressTec system, which uses plants as the production host and eliminates animal-derived components from gene to final product.
Cambridge Bioscience are pleased to distribute InVitria products in the UK and Ireland.
Learn more about InVitria or contact our InVitria specialists to discuss your project